InvestorsHub Logo
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Re: thefamilyman post# 323817

Wednesday, 09/16/2020 3:42:02 PM

Wednesday, September 16, 2020 3:42:02 PM

Post# of 403061


You can set up ”efficacy” as a strawman all you want but that changes nothing.



It's not a strawman, it was my entire statement. If you're disregarding efficacy, then Kevetrin, Humira, and Skittles are more advanced for COVID than Ab8 since they have shown safety in clinical trials. Discounting a more advanced efficacy test is foolish.

The most “advanced” drug will be the first to market and THAT is why Brilacidin is more “advanced” than Ab8.



We have no idea which will be first to market. If Ab8 gets picked up by a powerhouse BP, with all their lobbying power and FDA shortcuts, you might be surprised who makes it first.

I wouldn't even argue against the statement that "Brilacidin is more 'advanced' than Ab8" nor have I in any other post. It's my more specific statement about efficacy that you don't like. That's ok, that's what makes a market.

Brilacidin’s Phase 2 for Covid will be completed before Ab8 even begins a Phase 1.



Again, you're making factual statements about future events. We have no idea what development path Ab8 will take. We also have no idea what the results of Brilacidin will be against COVID in clinicals.

Go IPIX!

Make IPIX Great Again!

Because now it looks like we were absolute geniuses for purchasing our antibiotic from bankruptcy court a year ago for $5 million." - LE

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News